Board of Directors
Robert Mitchell,
Chairman of the Board, Director of Intellectual Property
Patent agent, retired partner at Ogilvy Renault (45 years)
Mr Mitchell joined the firm of Alan Swabey & Co. in 1963, where he eventually became a senior partner and was on the management committee. Swabey, Mitchell, Houle, Marcoux, & Sher eventually formed a partnership with the law firm of Ogilvy Renault in 1989 to become Swabey Ogilvy Renault. The two firms were merged in 2000 and where he was co-chair of the Intellectual Property Group, one of the largest in Canada and on the Executive Committee of the firm. In addition to being a very active member of AIPPI (International Association for the Protection of Intellectual Property) where he is a Member of Honour, he was also an active member of other professional organizations such as the Intellectual Property Institute of Canada (IPIC) where he is a past president and Honorary Member as well as the Fédération Internationale des Conseils en Propriété Industrielle (FICPI). He is a past president of the Canadian Group of this organization. He is also an author of several published papers on intellectual property and is the co-author of the History of the Patent Profession in Canada.
Serge Lebel, Corporate Lawyer, BCF
Secretary
Mr. Lebel has been a member of the Québec bar since 1983. During his years in practise, he has developed an expertise in business law covering commercial issues, construction, insurance, real estate and banking. His many board appointments include Société des loteries du Québec, Port of Québec city and the Interprovincial Lottery Corporation. He has also completed the Collège des administrateurs de société program and holds the title of certified society administrator (ASC).
Gamal Baroud PhD, President and CTO Skeltex Technologies
Director
Founder of Skeltex, professor at the University of Sherbrooke and a Canada Research Chair in Skeletal Reconstruction, Dr Baroud is an acknowledged key opinion leader (KOL) in the field and has developed a research initiative funded by the Canada Research Chair and the Canadian Institute of Health Research with the focus on overcoming existing clinical limitations of vertebroplasty, a surgical procedure where bone cement is injected percutaneously into a fractured vertebra with the goal of relieving the pain of compression fractures. The knowledge and science gained during the research process has been at the heart of Skeltex’ mission to bring consistency, simplicity and control (therefore safety) to vertebroplasty. Dr Baroud holds a Bachelor’s Degree from the Aachen University of Applied Science as well as a Master and PhD from the University of Technology of Chemnitz.
